HAMMONS KEVIN J 4

Accession 0000950170-24-024230

CIK 0001108109other

View on SEC.gov Company Profile

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 7:56 PM ET

Size

50.8 KB

Accession

0000950170-24-024230

Insider Transaction Report

Form 4

Period: 2024-03-01

COMMUNITY HEALTH SYSTEMS INCCYH

HAMMONS KEVIN J

VP/Chief Accounting Officer

Transactions

Award
Performance Based Restricted
2024-03-01+180,000→ 180,000 total
Exercise: $0.00→ Common Stock (180,000 underlying)
Disposition to Issuer
Performance Based Restricted
2024-03-01−30,000→ 0 total
Exercise: $0.00→ Common Stock (30,000 underlying)
Award
Stock Options (Right to Buy)
2024-03-01+90,000→ 90,000 total
Exercise: $2.87From: 2025-03-01Exp: 2034-02-28→ Common Stock (90,000 underlying)
Exercise/Conversion
Common Stock
2024-03-01+120,000→ 553,067 total
Award
Common Stock
2024-03-01+90,000→ 643,067 total
Tax Payment
Common Stock
2024-03-01$2.87/sh−78,701$225,872→ 564,366 total
Exercise/Conversion
Performance Based Restricted
2024-03-01−120,000→ 30,000 total
Exercise: $0.00→ Common Stock (120,000 underlying)

Holdings

Performance Based Restricted
Exercise: $0.00→ Common Stock (180,000 underlying)
180,000
Stock Options (Right to Buy)
Exercise: $4.99From: 2020-03-01Exp: 2029-02-28→ Common Stock (18,000 underlying)
18,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (150,000 underlying)
150,000
Stock Options (Right to Buy)
Exercise: $4.93From: 2021-03-01Exp: 2030-02-28→ Common Stock (47,500 underlying)
47,500
Stock Options (Right to Buy)
Exercise: $10.18From: 2023-03-01Exp: 2032-02-29→ Common Stock (75,000 underlying)
75,000
Stock Options (Right to Buy)
Exercise: $6.15From: 2024-03-01Exp: 2033-02-28→ Common Stock (90,000 underlying)
90,000
Stock Options (Right to Buy)
Exercise: $8.81From: 2022-03-01Exp: 2031-02-28→ Common Stock (75,000 underlying)
75,000

Footnotes (6)

[F1]The vesting of these 150,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (120,000), and the remaining 20% of the target number has been forfeited (30,000).
[F2]The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
[F3]The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 40% to a Cumulative Consolidated Adjusted EBITDA Growth target; 40% to a Cumulative Same-Store Net Revenue Growth target; and 20% to a Total Shareholder Return ("TSR") Percentile Rank target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
[F4]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
[F5]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
[F6]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.

Documents

2 files

Issuer

COMMUNITY HEALTH SYSTEMS INC

CIK 0001108109

→

Entity typeother

Related Parties

filerCIK 0001542264

Filing Metadata

Form type: 4
Filed: Feb 29, 7:00 PM ET
Accepted: Mar 1, 7:56 PM ET
Size: 50.8 KB

View on SEC.gov